share_log

天康生物:关于以债转股方式向全资子公司增资的进展公告

Tiankang Biotech: Announcement on the progress of capital increase to wholly-owned subsidiaries through debt-for-equity swaps

SZSI ·  Oct 30
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more